JVMCX | VASVX | JVMCX / VASVX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 13 years | 29 years | - |
Gain YTD | 3.755 | 2.476 | 152% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 23.1B | 6.61B | 349% |
Annual Yield % from dividends | 0.01 | 1.49 | 1% |
Returns for 1 year | 3.96 | -1.63 | -243% |
Returns for 3 years | -1.63 | -11.04 | 15% |
Returns for 5 years | 20.76 | 1.28 | 1,624% |
Returns for 10 years | 35.61 | 0.85 | 4,174% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JDIUX | 13.22 | 0.09 | +0.69% |
JHancock Disciplined Value Intl R6 | |||
BRKUX | 13.77 | 0.06 | +0.44% |
MFS Blended Research Em Mkts Eq R4 | |||
TRAIX | 35.24 | 0.13 | +0.37% |
T. Rowe Price Capital Appreciation I | |||
SCIZX | 7.14 | -0.02 | -0.28% |
Virtus SGA International Growth R6 | |||
CPLSX | 16.21 | -0.09 | -0.55% |
Calamos Phineus Long/Short A |